ACTIVE SUBSTANCE / INN

CABOZANTINIB S-MALATE

Brand name(s): COMETRIQ, CABOMETYX
FDA LISTED
PRESCRIPTION
NDA203756
NDA208692
ACTIVE SUBSTANCE
Cabozantinib S-Malate
REGULATORS
FDA
SPONSORS / MAH
EXELIXIS INC, EXELIXIS
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
COMETRIQNDA203756EXELIXISPrescription
CABOMETYXNDA208692EXELIXIS INCPrescription

FULL INTELLIGENCE ON CABOZANTINIB S-MALATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →